The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Citi Raises BHP Billiton And Rio Tinto To Buy

Fri, 10th Jul 2015 08:37

LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
CITIGROUP RAISES BHP BILLITON TO 'BUY' ('NEUTRAL') - PRICE TARGET 1400 (1500) PENCE
----------
CITIGROUP RAISES RIO TINTO TO 'BUY' - PRICE TARGET 2800 (2950) PENCE
----------
CITIGROUP CUTS RANDGOLD RESOURCES PRICE TARGET TO 4644 (5228) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS ANTOFAGASTA PRICE TARGET TO 600 (650) PENCE - 'SELL'
----------
EXANE BNP CUTS SMITHS GROUP PRICE TARGET TO 1090 (1125) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS BARCLAYS PRICE TARGET TO 287 (305) PENCE - 'BUY'
----------
EXANE BNP CUTS GKN PRICE TARGET TO 370 (380) PENCE - 'NEUTRAL'
----------
SOCGEN CUTS GKN PRICE TARGET TO 355 (400) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE PRICE TARGET TO 1490 (1540) PENCE - 'HOLD'
----------
EXANE BNP CUTS WEIR GROUP PRICE TARGET TO 1800 (1925) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES AB FOODS PRICE TARGET TO 3500 (3200) PENCE - 'OUTPERFORM'
----------
BERNSTEIN CUTS MARKS & SPENCER PRICE TARGET TO 535 (595) PENCE - MARKET-PERFORM
----------
BARCLAYS RAISES STANDARD LIFE PRICE TARGET TO 546 (520) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 1148 (1106) PENCE - OVERWEIGHT
----------
BARCLAYS RAISES RSA INSURANCE PRICE TARGET TO 436 (428) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES LEGAL & GENERAL PRICE TARGET TO 289 (285) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES AVIVA PRICE TARGET TO 637 (632) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES ADMIRAL GROUP PRICE TARGET TO 1572 (1523) PENCE - EQUAL WEIGHT
----------
BARCLAYS RAISES PRUDENTIAL PRICE TARGET TO 1889 (1877) PENCE - 'OVERWEIGHT'
----------
BERENBERG RAISES BAE SYSTEMS TO 'BUY' ('HOLD') - TARGET 570 (530) PENCE
----------
FTSE 250
----------
HSBC CUTS SYNTHOMER PRICE TARGET TO 285 (300) PENCE - 'HOLD'
----------
EXANE BNP CUTS VESUVIUS PRICE TARGET TO 470 (480) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS SPECTRIS PRICE TARGET TO 2415 (2500) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS ROTORK PRICE TARGET TO 200 (220) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK CUTS DRAX GROUP PRICE TARGET TO 270 (370) PENCE - 'HOLD'
----------
GOLDMAN CUTS DRAX GROUP PRICE TARGET TO 285 (411) PENCE - 'NEUTRAL'
----------
BERNSTEIN CUTS DRAX GROUP PRICE TARGET TO 370 (420) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS MELROSE PRICE TARGET TO 285 (310) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS IMI PRICE TARGET TO 1050 (1080) PENCE - 'UNDERPERFORM'
----------
EXANE BNP RAISES HALMA PRICE TARGET TO 850 (800) PENCE - 'OUTPERFORM'
----------
SOCGEN CUTS IMI PRICE TARGET TO 1400 (1450) PENCE - 'BUY'
----------
PANMURE RAISES BREWIN DOLPHIN HLDGS PRICE TARGET TO 350 (300) PENCE - 'BUY'
----------
SOCGEN INITIATES CRODA WITH 'BUY' - TARGET 3050 PENCE
----------
CITIGROUP CUTS POLYMETAL PRICE TARGET TO 465 (522) PENCE - 'SELL'
----------
JPMORGAN CUTS ASHMORE GROUP PRICE TARGET TO 265 (275) PENCE - 'UNDERWEIGHT'
----------
GOLDMAN CUTS ASHMORE GROUP PRICE TARGET TO 330 (343) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS PETRA DIAMONDS PRICE TARGET TO 180 (215) PENCE - 'BUY'
----------
JPMORGAN RAISES HAYS PRICE TARGET TO 155 (145) PENCE - 'NEUTRAL'
----------
UBS CUTS LONMIN TO 'SELL' ('NEUTRAL') - TARGET 75 (130) PENCE
----------
CITIGROUP CUTS LONMIN PRICE TARGET TO 113 (144) PENCE - 'NEUTRAL'
----------
CITIGROUP CUTS KAZ MINERALS PRICE TARGET TO 270 (300) PENCE - 'BUY'
----------
CITIGROUP RAISES ACACIA MINING PRICE TARGET TO 312 (283) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES DIGNITY PRICE TARGET TO 2260 (1850) PENCE - 'HOLD'
----------
UBS RAISES MICRO FOCUS PRICE TARGET TO 1460 (1420) PENCE - 'NEUTRAL'
----------
UBS RAISES HALFORDS GROUP PRICE TARGET TO 530 (485) PENCE - 'NEUTRAL'
----------
UBS RAISES DERWENT LONDON PRICE TARGET TO 3750 (3600) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES PHOENIX GROUP PRICE TARGET TO 794 (790) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS LANCASHIRE HLDGS PRICE TARGET TO 456 (463) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS CUTS HISCOX PRICE TARGET TO 607 (620) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS RAISES ESURE GROUP PRICE TARGET TO 300 (288) PENCE - 'OVERWEIGHT'
----------
BARCLAYS CUTS AMLIN PRICE TARGET TO 391 (407) PENCE - 'UNDERWEIGHT'
----------
SOCGEN CUTS ASHMORE GROUP PRICE TARGET TO 325 (350) PENCE - 'BUY'
----------
BERENBERG CUTS BALFOUR BEATTY PRICE TARGET TO 250 (260) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
CITIGROUP CUTS SOUTH32 PRICE TARGET TO 110 (140) PENCE - 'BUY'
----------
CITIGROUP RAISES PETROPAVLOVSK PRICE TARGET TO 6 (5) PENCE - 'SELL'
----------
CITIGROUP CUTS POLYUS GOLD PRICE TARGET TO 185 (194) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES HOCHSCHILD MINING PRICE TARGET TO 75 (65) PENCE - 'SELL'
----------
CITIGROUP CUTS GEM DIAMONDS PRICE TARGET TO 155 (161) PENCE - 'NEUTRAL'
----------
CITIGROUP RAISES FERREXPO PRICE TARGET TO 38 (31) PENCE - 'SELL'
----------
BARCLAYS RAISES PARTNERSHIP PRICE TARGET TO 117 (111) PENCE - 'UNDERWEIGHT'
----------
BERENBERG CUTS PENDRAGON PRICE TARGET TO 44 (45) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.